Dyne Therapeutics Inc (NASDAQ: DYN) started the day on Wednesday, with a price increase of 6.99% at $16.53, before settling in for the price of $15.45 at the close. Taking a more long-term approach, DYN posted a 52-week range of $6.36-$35.90.
The Healthcare sector firm’s twelve-monthly sales growth has been -59.45% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -59.45%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -8.03%. This publicly-traded company’s shares outstanding now amounts to $114.34 million, simultaneously with a float of $109.62 million. The organization now has a market capitalization sitting at $2.35 billion.
Dyne Therapeutics Inc (DYN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Dyne Therapeutics Inc’s current insider ownership accounts for 22.94%, in contrast to 71.83% institutional ownership. According to the most recent insider trade that took place on Sep 05 ’25, this organization’s CEO & President sold 2,640 shares at the rate of 13.41, making the entire transaction reach 35,402 in total value, affecting insider ownership by 199,539. Preceding that transaction, on Sep 04 ’25, Company’s Chief Commercial Officer sold 894 for 13.27, making the whole transaction’s value amount to 11,863. This particular insider is now the holder of 95,017 in total.
Dyne Therapeutics Inc (DYN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
Dyne Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -8.03% and is forecasted to reach -3.53 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.23% through the next 5 years, which can be compared against the -59.45% growth it accomplished over the previous five years trading on the market.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Let’s observe the current performance indicators for Dyne Therapeutics Inc (DYN). It’s Quick Ratio in the last reported quarter now stands at 16.83.
In the same vein, DYN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.86, a figure that is expected to reach -0.84 in the next quarter, and analysts are predicting that it will be -3.53 at the market close of one year from today.
